Semaglutide (the active ingredient in Ozempic and Wegovy) and similar GLP-1 drugs are far more effective at helping people lose weight than diet and exercise alone. But some scientists have also ...

In lab tests, people taking semaglutide drank less alcohol — and said they felt fewer cravings — than the people who were given a placebo.

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed these medications were 50% less likely to binge drink. The results were ...

Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...

Semaglutide and related weight-loss medications, known as GLP-1 agonists, may slow biological ageing, reduce inflammation, improve cognitive function and gut health, and reduce alcohol use in people ...

The new study looked at one of these drugs, semaglutide, ... an NIH researcher who is leading a 20-week trial of semaglutide for alcohol use disorder now underway in Baltimore. ...

Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...